Haisco Pharmaceutical Group Future Growth
Future criteria checks 5/6
Haisco Pharmaceutical Group is forecast to grow earnings and revenue by 39.1% and 21.7% per annum respectively. EPS is expected to grow by 38.7% per annum. Return on equity is forecast to be 14.8% in 3 years.
Key information
39.1%
Earnings growth rate
38.7%
EPS growth rate
Pharmaceuticals earnings growth | 18.3% |
Revenue growth rate | 21.7% |
Future return on equity | 14.8% |
Analyst coverage | Low |
Last updated | 15 Aug 2024 |
Recent future growth updates
Recent updates
With Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653) It Looks Like You'll Get What You Pay For
Jul 25Haisco Pharmaceutical Group (SZSE:002653) Has A Pretty Healthy Balance Sheet
Jul 04Calculating The Fair Value Of Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)
Jun 17These 4 Measures Indicate That Haisco Pharmaceutical Group (SZSE:002653) Is Using Debt Reasonably Well
Mar 19Risks To Shareholder Returns Are Elevated At These Prices For Haisco Pharmaceutical Group Co., Ltd. (SZSE:002653)
Feb 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,235 | 1,017 | 751 | 940 | 3 |
12/31/2025 | 5,017 | 628 | 319 | 645 | 4 |
12/31/2024 | 3,974 | 451 | 100 | 492 | 3 |
6/30/2024 | 3,672 | 385 | 143 | 505 | N/A |
3/31/2024 | 3,484 | 358 | 64 | 447 | N/A |
12/31/2023 | 3,355 | 295 | 59 | 450 | N/A |
9/30/2023 | 3,302 | 375 | -171 | 299 | N/A |
6/30/2023 | 3,138 | 282 | -447 | 204 | N/A |
3/31/2023 | 3,077 | 280 | -441 | 239 | N/A |
1/1/2023 | 3,015 | 277 | -606 | 95 | N/A |
9/30/2022 | 2,959 | 173 | -574 | 72 | N/A |
6/30/2022 | 2,744 | 95 | -617 | 17 | N/A |
3/31/2022 | 2,607 | 84 | -715 | -39 | N/A |
1/1/2022 | 2,773 | 345 | -667 | 36 | N/A |
9/30/2021 | 2,866 | 509 | -695 | 1 | N/A |
6/30/2021 | 3,154 | 728 | -342 | 290 | N/A |
3/31/2021 | 3,469 | 796 | -352 | 289 | N/A |
12/31/2020 | 3,330 | 637 | -396 | 206 | N/A |
9/30/2020 | 3,326 | 513 | -266 | 515 | N/A |
6/30/2020 | 3,520 | 488 | -282 | 499 | N/A |
3/31/2020 | 3,687 | 572 | 21 | 668 | N/A |
12/31/2019 | 3,937 | 494 | 182 | 764 | N/A |
9/30/2019 | 4,329 | 413 | 16 | 486 | N/A |
6/30/2019 | 4,105 | 423 | 32 | 365 | N/A |
3/31/2019 | 3,788 | 323 | 107 | 454 | N/A |
12/31/2018 | 3,427 | 333 | 121 | 473 | N/A |
9/30/2018 | 2,624 | 337 | 272 | 613 | N/A |
6/30/2018 | 2,208 | 247 | 201 | 571 | N/A |
3/31/2018 | 2,061 | 254 | N/A | 438 | N/A |
12/31/2017 | 1,856 | 238 | N/A | 392 | N/A |
9/30/2017 | 1,806 | 335 | N/A | 349 | N/A |
6/30/2017 | 1,606 | 341 | N/A | 313 | N/A |
3/31/2017 | 1,535 | 444 | N/A | 451 | N/A |
12/31/2016 | 1,436 | 443 | N/A | 409 | N/A |
9/30/2016 | 1,342 | 406 | N/A | 395 | N/A |
6/30/2016 | 1,326 | 395 | N/A | 474 | N/A |
3/31/2016 | 1,147 | 315 | N/A | 376 | N/A |
12/31/2015 | 1,212 | 372 | N/A | 443 | N/A |
9/30/2015 | 1,179 | 372 | N/A | 454 | N/A |
6/30/2015 | 1,233 | 434 | N/A | 455 | N/A |
3/31/2015 | 1,226 | 469 | N/A | 459 | N/A |
1/1/2015 | 1,211 | 451 | N/A | 503 | N/A |
9/30/2014 | 1,110 | 520 | N/A | 492 | N/A |
6/30/2014 | 1,067 | 524 | N/A | 522 | N/A |
3/31/2014 | 1,031 | 520 | N/A | 557 | N/A |
12/31/2013 | 992 | 519 | N/A | 568 | N/A |
9/30/2013 | 998 | 502 | N/A | 503 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002653's forecast earnings growth (39.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 002653's earnings (39.1% per year) are forecast to grow faster than the CN market (22% per year).
High Growth Earnings: 002653's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 002653's revenue (21.7% per year) is forecast to grow faster than the CN market (13.4% per year).
High Growth Revenue: 002653's revenue (21.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002653's Return on Equity is forecast to be low in 3 years time (14.8%).